In the type 2 diabetes mellitus subpopulation, at baseline, the mean eGFR was 36 mL/min/1.73 m, 17% of patients had an eGFR equal to or above 45 mL/min/1.73 m, and 45% had an eGFR 30 to less than 45 mL/min/1.73 m
Heres everything you need to know about why people switch, how it works, and what to watch for
Semaglutide GLP-1, a GLP-1 receptor agonist originally developed for diabetes treatment, has proven effective in lowering body weight
Gimme Care is a direct-to-consumer telehealth GLP-1 provider that prescribes compounded semaglutide and tirzepatide online, with medication shipped directly to patients
Navigating a Transition: Safely Switching Between Semaglutide and Tirzepatide While using semaglutide and tirzepatide concurrently or in an alternating weekly schedule is not recommended, transitioning from one medication to the other under strict medical supervision is a well-established practice for many individuals